Innovation Pharmaceuticals Inc (IPIX)

[LilyGDog]

Awesome post Pete!

Go Leo & IPIX!

IPIX is in a current state of the old story of the cat chasing its tail in that many wonder why if Brilacidin is so good that no BP has offered big bucks for it yet. Easy explanation:

1. Almost anyone with a whit of sense realizes how powerful, and safe, a drug Brilacidin is and that it can be used across a multitude of indications due to being anti viral, fungal, bacterial, inflammatory, and having immunotherapeutic properties and that the total of these indications are revenue streams that total well over $100B/yr.

2. IPIX mgt (Leo) knows the full value of Brilacidin (or at least the minimum starting value we know currently though not necessarily the entire value of it) and he will not sell/license it to BP for pennies on the dollar as all historical partnerships have evolved regarding biotech startups and BPs due to BS laws and FDA dealings that greatly favored BPs (since the BP lobby is the largest in DC).

3. As such, no current BP is going to throw LARGE, LARGE sums at a startup for a drug that hasn't PROVED itself on human subjects in a handsomely sized trial to ensure it is the real deal. The CV19 human trial test (that should be PRd this week IMO to have started)and the following EAU order for Brilacidin will take care of that for CV19 (but will IPIX have to have a partner for this indication? - I think not) and open the doors for immediate large trials for B-UC, further study of B across all major viruses, studies for B in respiratory diseases (COPD, Bronchitis, Athsma), etc will elevate Brilacidin (and defensin mimetics as a new arm of medicine)in 2021 as a world leader to elevate medicine across the globe.

4. So nothing happens prior to successful human trials, such trials haven't occurred yet nor success attained in them, BPs don't want to put themselves on the hook for MANY billions should B fail, IPIX doesn't want to take pennies on the dollar, so right now we are in a stasis resulting in no offers that are acceptable to Leo at this time, although there certainly could have been no offers even made at this time.

But the whole situation should start turning soon as the CV19 human trial commencement gets PRd, we maybe get good reports of patients on ventilators overseas showing drastic improvement, and the trial being finished sometime in very late Feb/ early Mar. Most likely won't get the final results prior to April but if results are as good as we expect I would imagine we get EUA for use by early March.

The UC trial, when found successful, will alone bring in many billions to IPIX most likely due to a partnership/licensing for the entire B-GI tract platform.

A successful CV19 trial leads to expectations for successful further research and human trials for other viruses that could cause B to be the go-to treatment for them as well worth more billions.

Bottom line: Stockholders should see tremendous returns on their investment.